Sign in Subscribe
Vaccines

AstraZeneca Pauses £200m Cambridge Investment as UK Pharmaceutical Industry Faces Setbacks

Strategic Insights

— 1 min read

AstraZeneca, Britain's largest company, has paused a planned £200m investment in its Cambridge research site, underscoring a challenging week for the UK pharmaceutical industry. The decision freezes the £200m project, which was set to create 1,000 jobs, and none of the company's £650m investment package in the UK is currently proceeding. This comes on the heels of AstraZeneca scrapping plans to invest £450m in its vaccine manufacturing plant in Merseyside in January, citing reduced British government support.

Key Takeaways:

  • AstraZeneca has paused a planned £200m investment in its Cambridge research site, which was set to create 1,000 jobs.
  • The decision freezes none of the company's £650m investment package in the UK, which was originally announced in March 2024.
  • In January, AstraZeneca scrapped plans to invest £450m in its vaccine manufacturing plant in Merseyside, citing reduced British government support.
  • The UK pharmaceutical industry faces further challenges, with US drugmaker Merck scrapping a £1bn London research centre and laying off 125 scientists in the capital.
  • Prominent scientist Sir John Bell warns that other big pharmaceutical companies will stop investing in the UK due to a lack of support.
  • Paul Naish, UK head of market access for Sanofi, calls for a "proper plan from the Treasury" for life sciences, stating that the UK has become "not a good place" to develop or sell drugs.

Statistics:

  • £200m: The planned AstraZeneca investment in Cambridge that has been paused.
  • 1,000: The number of jobs set to be created by the stalled Cambridge project.
  • £650m: The original investment package announced by AstraZeneca in UK, none of which is currently proceeding.
  • £450m: The investment scrapped by AstraZeneca in its vaccine manufacturing plant in Merseyside in January.
  • £1bn: The value of Merck's scrapped London research centre.
  • 125: The number of scientists laid off by Merck in London this year.
  • 800: The total number of people expected to be employed by the UK Discovery Centre, including 180 scientists.

Sources:

  • The Guardian
  • BBC Radio 4
  • Reuters
  • AstraZeneca spokesperson
  • Sir John Bell's statement to BBC Radio 4
  • Paul Naish's statement to The Guardian

Read more